Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRI
Biofrontera
$1.66
+10.7%
$1.37
$0.61
$13.42
$8.45M0.83646,464 shs62,560 shs
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
$1.50
-3.8%
$1.49
$1.33
$3.29
$15.26M1.3413,335 shs3,850 shs
Leafly Holdings, Inc. stock logo
LFLY
Leafly
$2.12
-0.5%
$2.89
$1.96
$16.00
$4.90M1.0677,189 shs7,740 shs
CareCloud, Inc. stock logo
MTBC
CareCloud
$3.10
$2.50
$6.75
$47.64M0.8563,000 shs66,900 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRI
Biofrontera
+10.67%-2.92%+40.68%+12.16%-85.97%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-3.97%+4.90%0.00%-3.23%-40.48%
Leafly Holdings, Inc. stock logo
LFLY
Leafly
-0.47%+1.92%-29.10%-54.89%-66.64%
CareCloud, Inc. stock logo
MTBC
CareCloud
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biofrontera Inc. stock logo
BFRI
Biofrontera
2.4458 of 5 stars
3.55.00.00.01.10.01.3
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
2.1552 of 5 stars
3.53.00.00.00.71.71.3
Leafly Holdings, Inc. stock logo
LFLY
Leafly
2.5398 of 5 stars
3.35.00.00.03.80.80.0
CareCloud, Inc. stock logo
MTBC
CareCloud
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biofrontera Inc. stock logo
BFRI
Biofrontera
3.00
Buy$18.00984.34% Upside
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
3.00
Buy$10.00566.67% Upside
Leafly Holdings, Inc. stock logo
LFLY
Leafly
2.50
Moderate Buy$6.00183.02% Upside
CareCloud, Inc. stock logo
MTBC
CareCloud
N/AN/AN/AN/A

Current Analyst Ratings

Latest LFLY, MTBC, COCP, and BFRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2024
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
4/1/2024
Leafly Holdings, Inc. stock logo
LFLY
Leafly
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $6.00
3/20/2024
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biofrontera Inc. stock logo
BFRI
Biofrontera
$34.07M0.25N/AN/A$3.16 per share0.53
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/A$2.59 per shareN/A
Leafly Holdings, Inc. stock logo
LFLY
Leafly
$42.25M0.12N/AN/A($5.72) per share-0.37
CareCloud, Inc. stock logo
MTBC
CareCloud
$139.60M0.00N/A2.43$6.58 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$20.13M-$15.82N/AN/AN/A-59.09%-344.98%-72.85%5/10/2024 (Estimated)
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$17.98M-$1.99N/AN/AN/AN/A-59.62%-54.62%5/20/2024 (Estimated)
Leafly Holdings, Inc. stock logo
LFLY
Leafly
-$9.50M-$4.92N/AN/A-22.48%N/A-39.85%5/9/2024 (Estimated)
CareCloud, Inc. stock logo
MTBC
CareCloud
$2.84M-$0.45N/AN/AN/A3.20%4.54%3.33%N/A

Latest LFLY, MTBC, COCP, and BFRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$0.57-$0.44+$0.13-$0.44N/AN/A
3/28/2024Q4 2023
Leafly Holdings, Inc. stock logo
LFLY
Leafly
-$1.41-$0.22+$1.19-$0.22$9.49 million$9.75 million
3/15/2024Q4 2023
Biofrontera Inc. stock logo
BFRI
Biofrontera
N/A-$2.33-$2.33-$6.31N/A$10.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biofrontera Inc. stock logo
BFRI
Biofrontera
N/AN/AN/AN/AN/A
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/AN/A
Leafly Holdings, Inc. stock logo
LFLY
Leafly
N/AN/AN/AN/AN/A
CareCloud, Inc. stock logo
MTBC
CareCloud
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biofrontera Inc. stock logo
BFRI
Biofrontera
N/A
1.28
0.67
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/A
8.92
8.92
Leafly Holdings, Inc. stock logo
LFLY
Leafly
N/A
3.74
3.74
CareCloud, Inc. stock logo
MTBC
CareCloud
N/A
1.21
1.19

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
10.08%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
6.72%
Leafly Holdings, Inc. stock logo
LFLY
Leafly
15.55%
CareCloud, Inc. stock logo
MTBC
CareCloud
19.68%

Insider Ownership

CompanyInsider Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
0.21%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
25.06%
Leafly Holdings, Inc. stock logo
LFLY
Leafly
11.30%
CareCloud, Inc. stock logo
MTBC
CareCloud
34.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Biofrontera Inc. stock logo
BFRI
Biofrontera
835.09 million5.08 millionNo Data
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
1210.17 million7.62 millionNot Optionable
Leafly Holdings, Inc. stock logo
LFLY
Leafly
1302.30 million2.04 millionOptionable
CareCloud, Inc. stock logo
MTBC
CareCloud
4,10015.22 million9.91 millionNot Optionable

LFLY, MTBC, COCP, and BFRI Headlines

SourceHeadline
CCLD Stock Earnings: CareCloud Beats EPS, Misses Revenue for Q4 2023CCLD Stock Earnings: CareCloud Beats EPS, Misses Revenue for Q4 2023
investorplace.com - March 21 at 12:09 PM
CareCloud (CCLD) Earnings Dates & ReportsCareCloud (CCLD) Earnings Dates & Reports
investing.com - March 3 at 3:18 PM
CareCloud, Inc. (NASDAQ:CCLD) Q2 2023 Earnings Call TranscriptCareCloud, Inc. (NASDAQ:CCLD) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 10 at 4:54 PM
CareCloud Inc Preferred Series B (CCLDO)CareCloud Inc Preferred Series B (CCLDO)
investing.com - May 17 at 2:50 PM
Revenue Cycle Management Market Technologies, Size and Market ... - Cottonwood Holladay JournalRevenue Cycle Management Market Technologies, Size and Market ... - Cottonwood Holladay Journal
news.google.com - May 11 at 6:23 PM
CareCloud CEO Hadi Chaudhry Named Finalist for Ernst & Youngs ... - GlobeNewswireCareCloud CEO Hadi Chaudhry Named Finalist for Ernst & Young's ... - GlobeNewswire
news.google.com - May 11 at 6:23 PM
Healthcare Cloud Computing Market Share In 2023 | Important ... - Digital JournalHealthcare Cloud Computing Market Share In 2023 | Important ... - Digital Journal
news.google.com - May 11 at 8:22 AM
Podiatry EMR Software Market Size Analysis Report 2023-2030 by ... - Digital JournalPodiatry EMR Software Market Size Analysis Report 2023-2030 by ... - Digital Journal
news.google.com - May 11 at 8:22 AM
CareCloud Wins Best Overall EHR Solution Provider in 2023 MedTech Breakthrough Awards - CareCloud (NASDAQ - BenzingaCareCloud Wins Best Overall EHR Solution Provider in 2023 MedTech Breakthrough Awards - CareCloud (NASDAQ - Benzinga
news.google.com - May 10 at 5:20 PM
Morning Medical Update: New breast cancer screening guidelines ... - Medical EconomicsMorning Medical Update: New breast cancer screening guidelines ... - Medical Economics
news.google.com - May 10 at 12:19 PM
3 lessons the HealthTech industry can learn from CareCloud - Medical Economics3 lessons the HealthTech industry can learn from CareCloud - Medical Economics
news.google.com - May 10 at 12:19 PM
CareClouds Bill Korn, Chief Strategy Officer, and Joseph DosSantos ... - GlobeNewswireCareCloud's Bill Korn, Chief Strategy Officer, and Joseph DosSantos ... - GlobeNewswire
news.google.com - May 9 at 11:01 AM
CareCloud Strengthens Leadership Team with Key Transitions - GlobeNewswireCareCloud Strengthens Leadership Team with Key Transitions - GlobeNewswire
news.google.com - May 8 at 8:00 PM
CareCloud CFO Bill Korn Named to New Role as Chief Strategy Officer - MarketWatchCareCloud CFO Bill Korn Named to New Role as Chief Strategy Officer - MarketWatch
news.google.com - May 8 at 3:00 PM
Workable Strategic Report on Medical Practice Management (PMS ... - Digital JournalWorkable Strategic Report on Medical Practice Management (PMS ... - Digital Journal
news.google.com - May 8 at 9:59 AM
CareCloud appoints DosSantos as CFO, Korn as CSO - Seeking AlphaCareCloud appoints DosSantos as CFO, Korn as CSO - Seeking Alpha
news.google.com - May 8 at 9:59 AM
CareCloud Strengthens Leadership Team with Key Transitions - Yahoo FinanceCareCloud Strengthens Leadership Team with Key Transitions - Yahoo Finance
news.google.com - May 8 at 9:59 AM
Recent Digital Health Strategic Partnerships Round Up - HIT ConsultantRecent Digital Health Strategic Partnerships Round Up - HIT Consultant
news.google.com - May 5 at 5:46 PM
EF Hutton Reiterates CareCloud (CCLD) Buy Recommendation - NasdaqEF Hutton Reiterates CareCloud (CCLD) Buy Recommendation - Nasdaq
news.google.com - May 5 at 5:46 PM
Rising Trends of Emergency Medicine EMR Software Market will ... - Digital JournalRising Trends of Emergency Medicine EMR Software Market will ... - Digital Journal
news.google.com - May 5 at 12:46 PM
CareCloud Reports First Quarter 2023 Results - Yahoo FinanceCareCloud Reports First Quarter 2023 Results - Yahoo Finance
news.google.com - May 5 at 12:46 PM
CareCloud Declares Dividends on Non-Convertible Series A and ... - InvestorsObserverCareCloud Declares Dividends on Non-Convertible Series A and ... - InvestorsObserver
news.google.com - May 5 at 12:46 PM
Gastroenterology EMR and Billing Software Market Size 2023 | New ... - Digital JournalGastroenterology EMR and Billing Software Market Size 2023 | New ... - Digital Journal
news.google.com - May 5 at 7:37 AM
Nexa Healthcare Announces Partnership with NexHealth to Offer 24 ... - EIN NewsNexa Healthcare Announces Partnership with NexHealth to Offer 24 ... - EIN News
news.google.com - May 4 at 4:36 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Biofrontera logo

Biofrontera

NASDAQ:BFRI
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Cocrystal Pharma logo

Cocrystal Pharma

NASDAQ:COCP
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.
Leafly logo

Leafly

NASDAQ:LFLY
Leafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. The company offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. Leafly Holdings, Inc. was founded in 2010 and is headquartered in Seattle, Washington.
CareCloud logo

CareCloud

NASDAQ:MTBC
CareCloud, Inc. brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and make better business and care decisions. More than 40,000 providers across the United States count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Services and solutions include revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth, and patient experience management (PXM). CareCloud is headquartered in Somerset, NJ.